Bupivacaine (USAN:INN:BAN)

HCID 2474CAS 2180-92-9

Basic information

Standard SMILES
CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C
InChIKey
LEBVLXFERQHONN-UHFFFAOYSA-N
Molecular formula
C18H28N2O
Average molar mass
288.4 g/mol
Monoisotopic mass
288.22016352

Overview

1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide is a piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline. It is a piperidinecarboxamide, a tertiary amino compound and an aromatic amide. It is a conjugate base of a 1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium.

Names & identifiers

Preferred name
Bupivacaine (USAN:INN:BAN)
IUPAC
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
English name
Bupivacaine
Molecular formula
C18H28N2O
Molecular weight
288.43

Names & synonyms

Bupivacaine [USAN:INN:BAN]2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+-)-Bupivacaine (USAN:INN:BAN)RefChem:1080208bupivacaine1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide2180-92-938396-39-3DL-BupivacaineBupivacainaAnekain(+-)-Bupivacaine
Show more names
BUPIVACAINE BASEMARCAINELevobupivacaine (Bupivacaine)1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamideLAC-43win11318WIN 11318Carbostesin
Bupivacainum1-Butyl-2',6'-pipecoloxylidideBupivacainum [INN-Latin]Bupivacaina [INN-Spanish]dl-1-Butyl-2',6'-pipecoloxylidideExparel(+/-)-BupivacaineAH 250

Database identifiers

CAS
2180-92-9、38396-39-3
PubChem CID
2474
DTXSID
DTXSID2022703
ChEBI
CHEBI:77431
UNII
Y8335394RO
Nikkaji
J7.351B

Properties

Computed structural properties

XLogP
3.4
Topological polar surface area
32.3 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
2
Rotatable bonds
5
Heavy atoms
21

Experimental & physicochemical properties

DrugsPharmaceuticals
LogP3.6
Solubility9.77e-02 g/L
Human DrugsPharmaceuticals
Animal DrugsPharmaceuticals -> UK Veterinary Medicines Directorate List
Melting Point107 - 108 °C

Physicochemical properties

Melting point
107.5 · 107.5-108°
Boiling point
430.65 °C · 430.65°C (rough estimate)
Density
1.0238 · 1.0238 (rough estimate)
refractive index
1.57 · 1.5700 (estimate)
pka
8.09 · 8.09; also reported as 8.17(at 25℃)
Water Solubility
101.5 mg/L · 101.5mg/L(25 ºC)

Safety & regulation

Safety data

ridadr
2811
risk_code
26/27/28-38-41
Signal word
Danger
Symbol(GHS)
GHS07,GHS05,GHS06
hazard_code
T+
safety_code
22-26-36/37/39-45

Chemistry & industry

Pharmacology

ATC CodeN01BB01
Cellular LocationsExtracellular
Metabolite PathwaysBupivacaine Action Pathway

Uses & manufacturing

Use ClassificationPharmaceuticals
Applications · 3 items

UsesAnesthetic (local).

UsesLike lidocaine and mepivacaine, bupivacaine is used in infiltration, spinal, and epidural anesthesia in blocking nerve transmission. Its most distinctive property is its long-lasting action. It is used for surgical intervention in urology and in lower thoracic surgery from 3 to 5 h in length, and in abdominal surgery lasting from 45 to 60 min. It is used to block the trifacial nerve, the sacral and brachial plexuses, in resetting dislocations, in epidural anesthesia, and during Cesarian sections.

General DescriptionBupivacaine was synthesized simultaneously with mepivacainein 1957 but was at first overlooked because of the increasedtoxicity compared with mepivacaine. When themethyl on the cyclic amine of mepivacaine is exchanged fora butyl group the lipophilicity, potency and the duration ofaction all increase. Literature reports of cardiovascular toxicity,including severe hypotension and bradycardia, areabundant in the literature.91 Bupivacaine is highly bound toplasma proteins (95%), and thus the free concentration mayremain low until all of the protein binding sites are occupied.After that point, the plasma levels of bupivacaine rise rapidlyand patients may progress to overt cardiac toxicity withoutever showing signs of CNS toxicity. The cardiotoxicity ofbupivacaine is a result of its affinity to cardiac tissues and itsability to depress electrical conduction and predispose theheart to reentry types of arrhythmias. The cardiotoxicity ofbupivacaine was found to be significantly more prominentwith the “R” isomer, or the racemic mixture, thus the “S”stereoisomer is now on the market as levobupivacaine.

Suppliers50 total

盐城通铭生物科技有限公司15195160625 · [email protected]
杭州品高化工有限公司0571-87658025 · [email protected]
上海毕得医药科技股份有限公司400-1647117 13681763483 · [email protected]
普善实业(陕西)有限公司029-81310890 18165209495 · [email protected]
Suzhou ARTK Medchem Co., Ltd.+86-18168183658 · [email protected]
Additional notes · 1 item

DefinitionChEBI: 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide is a piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline. It is a piperidinecarboxamide, an aromatic amide and a tertiary amino compound. It is a conjugate base of a 1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium.

Related reactions

12 records

Linked notes

Loading…